Targeting multiple epitopes on the spike protein: a new hope for COVID-19 antibody therapy

Affiliations

• ¹ CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 100101, Beijing, China.
• ² School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD, 4072, Australia. b.kobe@uq.edu.au.
• ³ CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 100101, Beijing, China. jxqi@im.ac.cn.
• ⁴ Savaid Medical School, University of the Chinese Academy of Sciences, 100049, Beijing, China. jxqi@im.ac.cn.